FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Sandoz Cyclophosphamide Injection 500 mg/5 mL Recall

Cyclophosphamide Injection 500 mg/5 mL (100 mg/mL), Hazardous Drug, Rx Only, Sterile, 5…

Sandoz Inc · Princeton, NJ

Risk level
Class II
Reported by FDA
Sep 24, 2025
Recall ID
D-0651-2025
Check your lot numberHow we source this data

Summary

Sandoz recalled Cyclophosphamide Injection 500 mg/5 mL starting Sep 5, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0651-2025 on Sep 24, 2025. Reason: cGMP deviations: Temperature excursion during transportation. Status: Ongoing.

Why it was recalled

cGMP deviations: Temperature excursion during transportation.

Product description

Cyclophosphamide Injection 500 mg/5 mL (100 mg/mL), Hazardous Drug, Rx Only, Sterile, 5mL Multiple Dose Vial, Manufactured in Austria by Fareva Unterach GmbH for Sandoz Inc., Princeton, NJ 08540, Product of India, Vial NDC# 0781-3528-75, Carton NDC# 0781-3528-10.

Lot numbers, UPCs & expiration codes

Only the following 6 GTN Numbers for Lot # 110459 exp. date 02/28/2027: (01)00307813528104(21)10686040629319 (01)00307813528104(21)10687281435306 (01)00307813528104(21)10687409963168 (01)00307813528104(21)10701200331212 (01)00307813528104(21)10687325644911 (01)00307813528104(21)10687661160169

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0651-2025
Classification
Class II
Status
Ongoing
Recall initiated
Sep 5, 2025
FDA report date
Sep 24, 2025
Quantity
6 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Sandoz Inc

Original FDA data

Every field from FDA enforcement report D-0651-2025, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Ongoing
Country
United States
Event ID
97549
Address
100 College Rd W
Code information
Only the following 6 GTN Numbers for Lot # 110459 exp. date 02/28/2027: (01)00307813528104(21)10686040629319 (01)00307813528104(21)10687281435306 (01)00307813528104(21)10687409963168 (01)00307813528104(21)10701200331212 (01)00307813528104(21)10687325644911 (01)00307813528104(21)10687661160169
Postal code
08540-6604
Report date
Sep 24, 2025
Product type
Drugs
Recall number
D-0651-2025
Classification
Class II
Recalling firm
Sandoz Inc
Product quantity
6 vials
Reason for recall
cGMP deviations: Temperature excursion during transportation.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Cyclophosphamide Injection 500 mg/5 mL (100 mg/mL), Hazardous Drug, Rx Only, Sterile, 5mL Multiple Dose Vial, Manufactured in Austria by Fareva Unterach GmbH for Sandoz Inc., Princeton, NJ 08540, Product of India, Vial NDC# 0781-3528-75, Carton NDC# 0781-3528-10.
Distribution pattern
Nationwide in the USA
Recall initiation date
Sep 5, 2025
Initial firm notification
Letter
Center classification date
Sep 15, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0651-2025, published Sep 24, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls